Showing results (1191-1200 of 1,512) with videos related to

Sort By:
Pageof 152
Cancer|December 6, 2012
Total lesion glycolysis in positron emission tomography is a better predictor of outcome than the International Prognostic Index for patients with diffuse large B cell lymphomaTae Min Kim, Jin Chul Paeng, In Kook Chun, et al.
Neurology|July 3, 2023
Presence of Embolic Source and Outcome in Central Retinal Artery OcclusionDong-Wan Kang, Keun-Hwa Jung, Wookjin Yang, et al.
BMC Cancer|November 4, 2014
A multicenter phase II study of everolimus in patients with progressive unresectable adenoid cystic carcinomaDong-Wan Kim, Do-Youn Oh, Seong Hoon Shin, et al.
Lung Cancer (Amsterdam, Netherlands)|September 8, 2006
Clinical predictors versus epidermal growth factor receptor mutation in gefitinib-treated non-small-cell lung cancer patientsSae-Won Han, Tae-You Kim, Kyung-Hun Lee, et al.
Genes & Genomics|May 26, 2020
A newly developed capture-based sequencing panel for genomic assay of lung cancerSun-Wha Im, Jeesoo Chae, Se Song Jang, et al.
International Journal of Oncology|January 3, 2020
Altered expression of fucosylation pathway genes is associated with poor prognosis and tumor metastasis in non‑small cell lung cancerSoonbum Park, Jin-Muk Lim, Jung Nyeo Chun, et al.
Blood|August 20, 2005
Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage I(E)/II(E) extranodal NK/T-cell lymphoma, nasal typeTae Min Kim, Yeon Hee Park, Sang-Yoon Lee, et al.
Hepato-Gastroenterology|March 14, 2014
Approaching pancreatic duct through pancreaticojejunostomy site with double ballon enteroscope in patients with Roux-en-Y anatomyJae-Ho Park, Byong Duk Ye, Jeong-Sik Byeon, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|May 29, 2024
Alcohol inducing macrophage M2b polarization in colitis by modulating the TRPV1-MAPK/NF-κB pathwaysZehua Zhang, Zhuyun Leng, Le Kang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 15, 2019
Osimertinib Plus Durvalumab versus Osimertinib Monotherapy in EGFR T790M-Positive NSCLC following Previous EGFR TKI Therapy: CAURAL Brief ReportJames Chih-Hsin Yang, Frances A Shepherd, Dong-Wan Kim, et al.
Pageof 152